| Anesthesia and Pain Management | Lifetime | 18 | US 9 | 99.77 |
| Pain Management and Opioid Use | Lifetime | 16 | US 13 | 99.59 |
| Anesthesia and Sedative Agents | Lifetime | 53 | US 27 | 99.41 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 217 | US 114 | 99.43 |
| Musculoskeletal pain and rehabilitation | Lifetime | 145 | US 50 | 99.42 |
| Nausea and vomiting management | Lifetime | 33 | US 15 | 99.27 |
| Opioid Use Disorder Treatment | Lifetime | 85 | US 66 | 98.91 |
| Pain Management and Treatment | Lifetime | 53 | US 19 | 98.43 |
| Spine and Intervertebral Disc Pathology | Lifetime | 357 | US 182 | 98.83 |
| Pain Mechanisms and Treatments | Lifetime | 252 | US 105 | 98.81 |
| COVID-19 and healthcare impacts | Lifetime | 250 | US 98 | 96.38 |
| Complementary and Alternative Medicine Studies | Lifetime | 149 | US 64 | 97.54 |
| Enhanced Recovery After Surgery | Lifetime | 126 | US 38 | 97.14 |
| Pediatric Pain Management Techniques | Lifetime | 287 | US 131 | 96.62 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 860 | US 315 | 96.24 |
| Pharmacology and Obesity Treatment | Lifetime | 375 | US 170 | 95.94 |
| Anesthesia and Neurotoxicity Research | Lifetime | 996 | US 468 | 94.93 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 387 | US 175 | 92.84 |
| Treatment of Major Depression | Lifetime | 564 | US 292 | 96.27 |
| Acupuncture Treatment Research Studies | Lifetime | 473 | US 104 | 93.59 |
| Electroconvulsive Therapy Studies | Lifetime | 517 | US 241 | 92.88 |
| Pain Management and Placebo Effect | Lifetime | 664 | US 292 | 92.08 |
| Peripheral Nerve Disorders | Lifetime | 987 | US 387 | 90.85 |
| Myofascial pain diagnosis and treatment | Lifetime | 716 | US 196 | 89.90 |
| Spinal Hematomas and Complications | Lifetime | 495 | US 239 | 88.21 |
| Phytochemistry Medicinal Plant Applications | Lifetime | 773 | US 54 | 87.29 |
| Intraoperative Neuromonitoring and Anesthetic Effects | Lifetime | 558 | US 236 | 82.66 |
| Sympathectomy and Hyperhidrosis Treatments | Lifetime | 888 | US 323 | 80.91 |
| Pathogenesis and Treatment of Hiccups | Lifetime | 356 | US 137 | 72.55 |
| Anesthesia and Pain Management | 2021-2025 | 1 | US 1 | 99.87 |
| Musculoskeletal pain and rehabilitation | 2021-2025 | 5 | US 2 | 99.73 |
| Pain Mechanisms and Treatments | 2021-2025 | 5 | US 3 | 99.50 |
| Pain Management and Opioid Use | 2021-2025 | 3 | US 2 | 99.52 |
| Spine and Intervertebral Disc Pathology | 2021-2025 | 29 | US 13 | 99.15 |
| Pain Management and Treatment | 2021-2025 | 6 | US 5 | 99.08 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 37 | US 11 | 97.81 |
| Anesthesia and Sedative Agents | 2021-2025 | 40 | US 16 | 97.15 |
| Shoulder Injury and Treatment | 2021-2025 | 110 | US 72 | 98.27 |
| Schizophrenia research and treatment | 2021-2025 | 135 | US 26 | 96.88 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 91 | US 21 | 96.21 |
| Opioid Use Disorder Treatment | 2021-2025 | 125 | US 91 | 96.83 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 578 | US 202 | 95.19 |
| Nausea and vomiting management | 2021-2025 | 42 | US 5 | 95.44 |
| Treatment of Major Depression | 2021-2025 | 101 | US 31 | 95.47 |
| Peripheral Nerve Disorders | 2021-2025 | 65 | US 27 | 93.53 |
| Cannabis and Cannabinoid Research | 2021-2025 | 247 | US 110 | 92.97 |
| Attention Deficit Hyperactivity Disorder | 2021-2025 | 249 | US 82 | 91.28 |
| Bipolar Disorder and Treatment | 2021-2025 | 385 | US 75 | 89.82 |
| Epilepsy research and treatment | 2021-2025 | 634 | US 208 | 90.67 |
| Sleep and related disorders | 2021-2025 | 731 | US 234 | 89.23 |
| Orthopedic Surgery and Rehabilitation | 2021-2025 | 866 | US 324 | 88.61 |
| Maternal Mental Health During Pregnancy and Postpartum | 2021-2025 | 798 | US 279 | 87.49 |
| Myofascial pain diagnosis and treatment | 2021-2025 | 193 | US 31 | 85.20 |
| Neurotransmitter Receptor Influence on Behavior | 2021-2025 | 378 | US 184 | 86.21 |
| Tendon Structure and Treatment | 2021-2025 | 587 | US 149 | 84.86 |
| Forensic Toxicology and Drug Analysis | 2021-2025 | 254 | US 66 | 85.67 |
| Neuroendocrine regulation and behavior | 2021-2025 | 460 | US 187 | 82.63 |
| Sleep and Wakefulness Research | 2021-2025 | 776 | US 254 | 85.03 |
| Circadian rhythm and melatonin | 2021-2025 | 681 | US 218 | 84.14 |
| Migraine and Headache Studies | 2021-2025 | 477 | US 121 | 85.83 |
| Sexual function and dysfunction studies | 2021-2025 | 522 | US 153 | 81.98 |
| Gastroesophageal reflux and treatments | 2021-2025 | 736 | US 208 | 81.41 |
| Nerve Injury and Rehabilitation | 2021-2025 | 459 | US 215 | 79.99 |
| Pain Management and Placebo Effect | 2021-2025 | 295 | US 73 | 81.37 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 865 | US 185 | 78.59 |
| Pharmacology and Obesity Treatment | 2021-2025 | 348 | US 156 | 77.53 |
| Pediatric Pain Management Techniques | 2021-2025 | 515 | US 153 | 76.32 |
| Dental Anxiety and Anesthesia Techniques | 2021-2025 | 455 | US 39 | 75.75 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 362 | US 81 | 78.25 |
| Hormonal and reproductive studies | 2021-2025 | 830 | US 200 | 75.75 |
| Drug-Induced Adverse Reactions | 2021-2025 | 597 | US 130 | 75.15 |
| Acupuncture Treatment Research Studies | 2021-2025 | 773 | US 63 | 70.19 |
| Electroconvulsive Therapy Studies | 2021-2025 | 408 | US 116 | 71.33 |
| Pharmacological Receptor Mechanisms and Effects | 2021-2025 | 342 | US 114 | 64.85 |
| Sympathectomy and Hyperhidrosis Treatments | 2021-2025 | 257 | US 68 | 64.11 |
| Intramuscular injections and effects | 2021-2025 | 137 | US 28 | 66.30 |
| Potassium and Related Disorders | 2021-2025 | 664 | US 223 | 62.51 |
| Electrolyte and hormonal disorders | 2021-2025 | 940 | US 225 | 59.66 |
| Spinal Hematomas and Complications | 2021-2025 | 780 | US 264 | 47.57 |
| Alcoholism and Thiamine Deficiency | 2021-2025 | 422 | US 125 | 47.78 |
| Foreign Body Medical Cases | 2021-2025 | 675 | US 119 | 23.02 |